Skip to content

13F-HR filed by SABBY MANAGEMENT, LLC

SABBY MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 28 holding rows worth $45,072,964.

Accession
0001104659-26-061764
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 28 entries on the cover page, a total value of $45,072,964 stated on the cover page (in dollars after the unit check, H1), rows summing to $45,072,964 with VALUE read as dollars as filed, 13F file number 028-15245. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerHal Mintz

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR S&P 500 ETF TR78462F953PUT447$29,070,198dollars as filedput
ISHARES TR464287955PUT300$7,440,000dollars as filedput
SPY78462F103SHS2,734$1,778,030dollars as filed
GEVO INC374396956COM PAR5,252$1,433,796dollars as filedput
ABIVAX SA00370M903CALL77$857,395dollars as filedcall
ALPHA COMPUTE CORPG7185A136SHS NEW2,072,103$654,785dollars as filed
BRIACELL THERAPEUTICS CORP107930125*W EXP 01/15/203380,686$392,145dollars as filed
SENESTECH INC81720R604COM NEW218,533$358,394dollars as filed
BIG TREE CLOUD HLDGS LTDG1263B132SHS CL A137,611$337,147dollars as filed
ZEVRA THERAPEUTICS488445956COM340$316,880dollars as filedput
BRIACELL THERAPEUTICS CORP107930307COM73,915$309,704dollars as filed
SIDUS SPACE INC826165951CL A1,049$243,368dollars as filedput
TOKEN CAT LTD89856T401SPONSORED ADS23,239$241,686dollars as filed
POP CULTURE GROUP CO LTDG71700119SHS NEW664,449$201,129dollars as filed
MOLECULIN BIOTECH INC60855D408COM75,021$171,798dollars as filed
BIODEXA PHARMACEUTICALS PLC ADR59564R880COM257,472$159,092dollars as filed
ARCADIA BIOSCIENCES INC039014303COM114,554$158,085dollars as filed
TRX GOLD CORPORATION87283P109COM100,000$150,000dollars as filed
INMED PHARMACEUTICALS INC457637700COM NEW220,260$142,046dollars as filed
CAN FITE BIOFARMA LTD13471N409SPONSORED ADR42,559$131,933dollars as filed
CHINA SXT PHARMACEUTICALS ING2161P165USD CL A ORD SHS78,170$131,326dollars as filed
REVELATION BIOSCIENCES INC76135L804COM 202599,432$119,318dollars as filed
CALIDI BIOTHERAPEUTICS INC320703408COM434,903$103,855dollars as filed
BLUEJAY DIAGNOSTICS INC095633608COM NEW28,726$52,856dollars as filed
LYRA THERAPEUTICS INC55234L204COM NEW104,059$51,103dollars as filed
TEMPEST THERAPEUTICS INC87978U207COM NEW17,856$29,284dollars as filed
BRIACELL THERAPEUTICS CORP107930117*W EXP 99/99/999206,753$28,945dollars as filed
BNB PLUS CORP03815U607COM NEW13,541$8,666dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-061764this filing2026-05-15acceptance time not in the bulk data set